Cancers (Sep 2022)

Quality of Life and Cognitive Function Evaluations and Interventions for Patients with Brain Metastases in the Radiation Oncology Clinic

  • Jennifer K. Matsui,
  • Haley K. Perlow,
  • Cyril Baiyee,
  • Alex R. Ritter,
  • Mark V. Mishra,
  • Joseph A. Bovi,
  • Vinai Gondi,
  • Paul D. Brown,
  • Ashlee R. Loughan,
  • Heather E. Leeper,
  • Erica Dawson,
  • Joshua D. Palmer

DOI
https://doi.org/10.3390/cancers14174301
Journal volume & issue
Vol. 14, no. 17
p. 4301

Abstract

Read online

Brain metastases (BMs) account for a disproportionately high percentage of cancer morbidity and mortality. Historically, studies have focused on improving survival outcomes, and recent radiation oncology clinical trials have incorporated HRQOL and cognitive assessments. We are now equipped with a battery of assessments in the radiation oncology clinic, but there is a lack of consensus regarding how to incorporate them in modern clinical practice. Herein, we present validated assessments for BM patients, current recommendations for future clinical studies, and treatment advances that have improved HRQOL and cognitive outcomes for BM patients.

Keywords